How Does Parainfluenza Spread In Communities?
Published on: March 18, 2025
How Does Parainfluenza Spread In Communities?
Article author photo

Priscilla Gomes da Silva

Masters in Neuroscience & Human Biology

Article reviewer photo

Chandana Raccha

MSc in Pharmacology and Drug Discovery, Coventry University

Human Parainfluenza viruses (HPIVs) are a group of enveloped RNA viruses belonging to the Paramyxoviridae family, in the genus Paramyxovirus.1 There are four types (1 through 4) and two subtypes (4a and 4b) of HPIVs.2 They are significant human respiratory pathogens, causing mild upper and lower respiratory tract infections to more severe conditions such as croup (laryngotracheobronchitis), bronchiolitis, and pneumonia,3 affecting mainly infants and small children.4 Seasonal HPIV epidemics place a major burden of disease on children, accounting for 40% of pediatric hospitalisations for lower respiratory tract infections (LRTIs) and 75% of croup cases.5 Understanding how parainfluenza is transmitted within the community is important for implementing effective control measures and mitigating its impact and burden on public health. 

Parainfluenza serotypes and seasonality

Human parainfluenza viruses are classified within four serotypes according to genetic and antigenic variation.6 HPIV2 and HPIV4 (subtypes HPIV4A and HPIV4B) are classified within the genus Rubulavirus, whereas HPIV1 and HPIV3 are placed into the genus Respirovirus.7,8

Human parainfluenza virus type 1 (HPIV-1)

HPIV-1 has been reported as a biennial fall epidemic.9 One of the main manifestations of HPIV-1 infection is croup, a viral infection characterised by inflammation of the larynx and upper airways, leading to a barking cough, hoarse voice and difficulty breathing. Additionally, symptoms such as fever, runny nose, nasal congestion, and sore throat may also occur. In severe cases, respiratory distress and difficulty breathing may develop.1

Human parainfluenza virus type 2 (HPIV-2)

HPIV-2 outbreaks are typically smaller in scale and occur biennially in alternate years with HPIV-1, although they can also cause yearly outbreaks.9 HPIV-2 infection typically manifests as mild to moderate respiratory illness, with symptoms resembling those of a common cold.1 Patients may experience nasal congestion, runny nose, cough, and mild fever. Unlike HPIV-1, severe manifestations such as croup are less commonly associated with HPIV-2 infection.10 Lower respiratory tract involvement leading to bronchiolitis or pneumonia may occur in some patients such as young children and immunocompromised individuals.

Human parainfluenza virus type 3 (HPIV-3)

HPIV-3 outbreaks are reported to happen annually, mainly from April to June. In years when HPIV-1 is not prevalent (even-numbered years), HPIV-3 often experiences an extended spring season that may extend into fall or a secondary increase in activity from November to December.9 Symptoms of HPIV-3 infection include fever, runny nose and cough, but in some cases, it can evolve to conditions such as bronchiolitis, bronchitis and pneumonia.11,12 As with the other HPIV serotypes, infants and young children and more vulnerable to HPIV-3 infections, as well as older adults and individuals with compromised immune systems.13

Human parainfluenza virus type 4 (HPIV-4)

HPIV-4 is rare and displays a seasonality pattern similar to that of HPIV-3.9 It is known to cause mostly upper respiratory tract infections in children and adults.15 PIV-4 is further divided into two subtypes, PIV-4A and PIV-4B.16 PIV-4 infections are generally less common and less severe when compared to PIV-1, PIV-2, and PIV-3.14 They can cause mild respiratory symptoms similar to the common cold, such as nasal congestion, runny nose, sore throat, and cough. Severe cases have been reported in young children and immunocompromised patients.17

Modes of transmission

According to the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC), there are at least three transmission routes for respiratory viruses,18 These are:

Contact transmission

It occurs when virus-containing respiratory secretions from an infected individual come in contact with a susceptible person. This can happen directly through physical contact or indirectly through contact with contaminated surfaces or objects (fomites).16

Droplet transmission

It occurs when an infected person expels virus-containing respiratory droplets, which land on mucosal surfaces (such as the eyes, nose, and mouth) of a susceptible person.19 Respiratory droplets can travel relatively short distances, typically within a radius of about 6 feet, making close contact with infected individuals a significant risk factor.20,21

Airborne or aerosol transmission

While respiratory droplets are the primary mode of transmission for parainfluenza viruses, there is also evidence to suggest the potential for aerosol transmission in certain circumstances.2 Aerosols are smaller respiratory particles that can remain suspended in the air for longer periods and travel greater distances when compared to respiratory droplets.22 These aerosols can be produced by the exhalation of an infected person during talking, breathing, coughing, singing or sneezing,23 or by aerosol-generating medical procedures. Susceptible individuals can inhale these droplets, resulting in infection.

Factors influencing community spread

Several factors contribute to the spread of parainfluenza within the community, such as:

  • Seasonality: Parainfluenza infections often exhibit seasonal patterns,24 with peaks occurring in the fall and winter months in temperate regions.25 This seasonality may be influenced by factors such as changes in weather conditions, school openings, and increased indoor crowding during colder months26
  • Viral Shedding: Infected individuals can shed parainfluenza virus particles in respiratory secretions several days before the onset of symptoms and continue shedding for up to two weeks or longer after symptoms resolve.27 Asymptomatic or pre-symptomatic shedding can contribute to the transmission of the virus in the community, making it challenging to identify and isolate cases
  • Population Susceptibility: The susceptibility of the population to parainfluenza viruses can vary depending on factors such as age, underlying health conditions, and immune status.2 Infants, young children, older adults, and individuals with weakened immune systems are at increased risk of severe disease following parainfluenza infection9
  • Crowded Environments: Environments where people gather close by, such as schools, pubs, public transport, daycare centres, nursing homes, and healthcare facilities, can facilitate the transmission of parainfluenza viruses. Transmission through close contact and the airborne route is facilitated in these crowded settings, particularly among susceptible individuals28

Prevention measures for parainfluenza viruses

To prevent the spread of parainfluenza viruses in the community, several control measures can be implemented,29 such as:

  • Hand Hygiene: Frequent handwashing with soap and water or the use of alcohol-based hand sanitisers can reduce the risk of transmitting and acquiring parainfluenza viruses during close personal contact such as shaking hands, as well as through contaminated surfaces as it also reduces the contamination of frequently touched surfaces and objects
  • Respiratory Protection: Promoting respiratory protection habits such as covering coughs and sneezes with a tissue or the elbow, can help prevent the spread of respiratory droplets containing the virus from infected people. Wearing masks whenever you have respiratory disease symptoms or are around someone showing respiratory symptoms is also another effective prevention measure to avoid infection by not only influenza but other respiratory viruses as well
  • Physical Distancing: Maintaining physical distance from others, especially in crowded settings, can reduce the risk of exposure to respiratory droplets and minimize the transmission of parainfluenza viruses
  • Environmental Cleaning: Regular cleaning and disinfection of frequently touched surfaces and objects can help reduce the presence of viable virus particles and interrupt the transmission cycle
  • Vaccination: While no specific vaccine targeting parainfluenza viruses is currently available for widespread use, efforts to develop and deploy vaccines against certain strains of parainfluenza are ongoing and may provide future opportunities for disease prevention2

Conclusion

In conclusion, parainfluenza viruses spread within the community primarily through respiratory droplets, contaminated surfaces, and close personal contact such as touching or holding hands. Factors such as seasonality, viral shedding, population susceptibility, and crowded settings contribute to the transmission dynamics of parainfluenza viruses. Prevention measures such as hand hygiene, respiratory etiquette, physical distancing, environmental cleaning and disinfection, and vaccination can help mitigate the spread of parainfluenza and reduce its impact on public health.

FAQ’s

What are the primary modes of transmission for parainfluenza?

Parainfluenza viruses are primarily transmitted through respiratory droplets produced by infected people coughing, sneezing, or talking. These droplets can be swallowed by close people, enhancing transmission. Furthermore, the virus can be transmitted by contact with contaminated surfaces or intimate physical contact with infected individuals.

Can parainfluenza spread through the air?

While respiratory droplets are the primary mechanism of transmission, there is evidence that aerosol transfer may occur in some conditions. Aerosols, which are smaller respiratory particles, can remain suspended in the air for longer periods and travel further than respiratory droplets.

Who is most at risk of parainfluenza infection?

Parainfluenza viruses can infect people of all ages and groups, such as young children, newborns, the elderly, and those with compromised immune systems, who are more likely to become seriously ill. Close contact with infected people, crowded environments, and poor respiratory hygiene habits enhance the chance of transmission.

How can parainfluenza transmission be prevented?

Preventive strategies include washing your hands frequently, covering coughs and sneezes with a tissue or elbow, avoiding close contact with ill people and frequent sanitization of touched surfaces. Vaccination programs may potentially offer prospects for disease prevention.

What should I do if I suspect I've been exposed to parainfluenza?

If you feel you have been exposed to parainfluenza or have symptoms such as fever, cough, sore throat, or difficulty breathing, get medical attention immediately. Healthcare professionals can provide advice on testing, treatment, and preventive measures to keep you and others safe from further spread.

References

  1. Henrickson KJ. Parainfluenza viruses. Clin Microbiol Rev. 2003 Apr;16(2):242–64.
  2. CDC. Clinical Overview. 2022 [cited 2024 May 10]. Human Parainfluenza Viruses (HPIVs). Available from: https://www.cdc.gov/parainfluenza/hcp/clinical.html
  3. Weston S, Frieman MB. Respiratory viruses [Internet]. 4th ed. Encyclopedia of Microbiology. Elsevier Inc.; 2019. 85–101 p. Available from: http://dx.doi.org/10.1016/B978-0-12-801238-3.66161-5
  4. Vainionpää R, Hyypiä T. Biology of parainfluenza viruses. Clin Microbiol Rev. 1994 Apr;7(2):265–75.
  5. Branche AR, Falsey AR. Parainfluenza Virus Infection. 2016;538–54.
  6. Shao N, Liu B, Xiao Y, Wang X, Ren L, Dong J, et al. Genetic Characteristics of Human Parainfluenza Virus Types 1–4 From Patients With Clinical Respiratory Tract Infection in China. Front Microbiol. 2021;12(July):1–14.
  7. CANCHOLA J, VARGOSKO AJ, KIM HW, PARROTT RH, CHRISTMAS E, JEFFRIES B, et al. ANTIGENIC VARIATION AMONG NEWLY ISOLATED STRAINS OF PARAINFLUENZA TYPE 4 VIRUS. Am J Hyg. 1964 May;79:357–64.
  8. Zhong P, Zhang H, Chen X, Lv F. Clinical characteristics of the lower respiratory tract infection caused by a  single infection or coinfection of the human parainfluenza virus in children. J Med Virol. 2019 Sep;91(9):1625–32.
  9. Elboukari H AM. StatPearls. 2023. Parainfluenza Virus.
  10. Burrell CJ, Howard CR, Murphy FA. Chapter 26 - Paramyxoviruses. In: Burrell CJ, Howard CR, Murphy FABTF and WMV (Fifth E, editors. London: Academic Press; 2017. p. 367–82. Available from: https://www.sciencedirect.com/science/article/pii/B9780123751560000266
  11. National Center for Advancing Translational Sciences (NIH). Genetic and Rare Diseases Information Center (GARD). 2024 [cited 2024 May 10]. Parainfluenza virus type 3. Available from: https://rarediseases.info.nih.gov/diseases/4215/parainfluenza-virus-type-3
  12. Teo WY, Rajadurai VS, Sriram B. Morbidity of parainfluenza 3 outbreak in preterm infants in a neonatal unit. Ann Acad Med Singapore. 2010 Nov;39(11):836–7.
  13. Crowe JEJ. Human Respiratory Viruses. Reference Module in Biomedical Sciences. 2014.
  14. ARRUDA E, CINTRA OAL, HAYDEN FG. Chapter 59 - Respiratory Tract Viral Infections. In: Guerrant RL, Walker DH, Weller PFBTTID (Second E, editors. Philadelphia: Churchill Livingstone; 2006. p. 637–59. Available from: https://www.sciencedirect.com/science/article/pii/B9780443066689500648
  15. Proença-Módena JL, Acrani GO, Snider CB, Arruda E. Respiratory Viral Infections [Internet]. Thrid Edition. Tropical Infectious Diseases: Principles, Pathogens and Practice. Elsevier Inc.; 2011. 378–391 p. Available from: http://dx.doi.org/10.1016/B978-0-7020-3935-5.00058-6
  16. Zaki SR, Keating MK. 13 - Viral Diseases. In: Zander DS, Farver CFBTPP (Second E, editors. Foundations in Diagnostic Pathology [Internet]. Philadelphia: Elsevier; 2018. p. 244–88. Available from: https://www.sciencedirect.com/science/article/pii/B9780323393089000133
  17. Wang L, Lu S, Guo Y, Liu J, Wu P, Yang S. Epidemiology and clinical severity of the serotypes of human parainfluenza virus in children with acute respiratory infection. Virol J. 2023;20(1):1–7.
  18. Li Y. Basic routes of transmission of respiratory pathogens—A new proposal for transmission categorization based on respiratory spray, inhalation, and touch. Indoor Air [Internet]. 2021 Jan 1;31(1):3–6. Available from: https://doi.org/10.1111/ina.12786
  19. Leung NHL. Transmissibility and transmission of respiratory viruses. Nat Rev Microbiol. 2021 Aug;19(8):528–45.
  20. World Health Organization. Natural Ventilation for Infection Control in Health-Care Settings. 2009;
  21. Kim T, Jin CE, Sung H, Koo B, Park J, Kim SM, et al. Molecular epidemiology and environmental contamination during an outbreak of  parainfluenza virus 3 in a haematology ward. J Hosp Infect. 2017 Dec;97(4):403–13.
  22. Wang CC, Prather KA, Sznitman J, Jimenez JL, Lakdawala SS, Tufekci Z, et al. Airborne transmission of respiratory viruses. Science (80- ) [Internet]. 2024 May 10;373(6558):eabd9149. Available from: https://doi.org/10.1126/science.abd9149
  23. Burke CW, Bridges O, Brown S, Rahija R, Russell CJ. Mode of parainfluenza virus transmission determines the dynamics of primary  infection and protection from reinfection. PLoS Pathog. 2013;9(11):e1003786.
  24. Fry AM, Curns AT, Harbour K, Hutwagner L, Holman RC, Anderson LJ. Seasonal Trends of Human Parainfluenza Viral Infections: United States, 1990–2004. Clin Infect Dis [Internet]. 2006 Oct 15;43(8):1016–22. Available from: https://doi.org/10.1086/507638
  25. Howard LM, Rankin DA, Spieker AJ, Gu W, Haddadin Z, Probst V, et al. Clinical features of parainfluenza infections among young children hospitalized  for acute respiratory illness in Amman, Jordan. BMC Infect Dis. 2021 Apr;21(1):323.
  26. Kronfeld-Schor N, Stevenson TJ, Nickbakhsh S, Schernhammer ES, Dopico XC, Dayan T, et al. Drivers of Infectious Disease Seasonality: Potential Implications for COVID-19. J Biol Rhythms. 2021 Feb;36(1):35–54.
  27. Mejías A, Ramilo O. 223 - Parainfluenza Viruses. In: Long SS, Prober CG, Fischer MBTP and P of PID (Fifth E, editors. Elsevier; 2018. p. 1152-1157.e3. Available from: https://www.sciencedirect.com/science/article/pii/B9780323401814002231
  28. Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane database Syst Rev. 2011 Jul;2011(7):CD006207.
  29. CDC. Prevention and Treatment. 2022 [cited 2024 May 10]. Human Parainfluenza Viruses (HPIVs). Available from: https://www.cdc.gov/parainfluenza/prevention-treatment.html
Share

Priscilla Gomes da Silva

Masters in Neuroscience & Human Biology

Priscilla Gomes da Silva is a distinguished and driven professional with a comprehensive background in molecular biology, immunology, and epidemiology.

With over eight years of experience with infectious viruses and epidemiology, she displays an extensive scientific production, including publications on airborne SARS-CoV-2 detection and zoonotic flaviviral infections, highlighting her broad expertise in virology, environmental microbiology, and public health.

She is currently in the last semester of a Doctorate Degree program at the School of Medicine and Biomedical Sciences, Porto University, reflecting her commitment to continuous learning and research excellence.

arrow-right